Brazilian Journal of Anesthesiology
Brazilian Journal of Anesthesiology
Scientific Article

Effects of dexmedetomidine in conjunction with remote ischemic preconditioning on renal ischemia–reperfusion injury in rats

Efeitos de dexmedetomidina em conjunto com o pré-condicionamento isquêmico remoto em lesão de isquemia-reperfusão renal em ratos

Emine Bagcik; Sevda Ozkardesler; Nilay Boztas; Bekir Ugur Ergur; Mert Akan; Mehmet Guneli; Sule Ozbilgin

Downloads: 1
Views: 689


Background and objectives: The aim of this study was to evaluate the effects of remote ischemic preconditioning by brief ischemia of unilateral hind limb when combined with dexmedetomidine on renal ischemia-reperfusion injury by histopathology and active caspase-3 immunoreactivity in rats. Methods: 28 Wistar albino male rats were divided into 4 groups. Group I (Sham, n = 7): Laparotomy and renal pedicle dissection were performed at 65th minute of anesthesia and the rats were observed under anesthesia for 130min. Group II (ischemia-reperfusion, n = 7): At 65th minute of anesthesia bilateral renal pedicles were clamped. After 60 min ischemia 24 h of reperfusion was performed. Group III (ischemia-reperfusion + dexmedetomidine, n = 7): At the fifth minute of reperfusion (100 μg/kg intra-peritoneal) dexmedetomidine was administered with ischemia-reperfusion group. Reperfusion lasted 24 h. Group IV (ischemia-reperfusion + remote ischemic preconditioning + dexmedetomidine, n = 7): After laparotomy, three cycles of ischemic preconditioning (10 min ischemia and 10 min reperfusion) were applied to the left hind limb and after 5 min with group III. Results: Histopathological injury scores and active caspase-3 immunoreactivity were significantly lower in the Sham group compared to the other groups. Histopathological injury scores in groups III and IV were significantly lower than group II (p = 0.03 and p = 0.05). Active caspase-3 immunoreactivity was significantly lower in the group IV than group II (p = 0.01) and there was no significant difference between group II and group III (p = 0.06). Conclusions: Pharmacologic conditioning with dexmedetomidine and remote ischemic preconditioning when combined with dexmedetomidine significantly decreases renal ischemia- reperfusion injury histomorphologically. Combined use of two methods prevents apoptosis via active caspase-3.


Kidney, Ischemia-reperfusion injury, Dexmedetomidine, Caspase-3, Ischemic preconditioning, Apoptosis


Justificativa e objetivos: Avaliar os efeitos do pré-condicionamento isquêmico remoto, mediante breve isquemia de membro posterior unilateral, em combinação com dexmedetomidina em lesão de isquemia-reperfusão renal por meio de histopatologia e imunorreatividade da caspase-3 ativa em ratos. Métodos: Foram divididos em quatro grupos 28 ratos machos albinos Wistar. Grupo I (Sham cirurgia controle], n = 7): laparotomia e dissecção do pedículo renal foram feitas em 65 minutos de anestesia e os ratos foram observados sob anestesia por 130 minutos. Grupo II (isquemia-reperfusão, n = 7): no 65° minuto de anestesia, os pedículos renais bilaterais foram pinçados; após 60 minutos de isquemia, foi feita reperfusão de 24 horas. Grupo III (isquemia-reperfusão + dexmedetomidina, n = 7): no quinto minuto de reperfusão, dexmedetomidina (100 mg/kg intraperitoneal) foi administrada ao grupo com isquemia-reperfusão. A reperfusão durou 24 horas. Grupo IV (isquemia-reperfusão + pré-condicionamento isquêmico remoto + dexmedetomidina, n = 7): após a laparotomia, três ciclos de pré-condicionamento isquêmico (10minutos de isquemia e 10minutos de reperfusão) foram aplicados no membro posterior esquerdo e depois de cincominutos ao grupo III. Resultados: Os escores de lesão histopatológica e imunorreatividade da caspase-3 ativa foram significativamente menores no grupo Sham em comparação com os outros. Os escores de lesão histopatológica dos grupos III e IV foram significativamente menores do que os do II (p = 0,03 e p = 0,05). A imunorreatividade da caspase-3 foi significativamente menor no grupo IV do que no II (p = 0,01) e não houve diferença significante entre os grupos II e III (p = 0,06). Conclusões: O condicionamento farmacológico com dexmedetomidina e o pré-condicionamento isquêmico remoto em combinação com dexmedetomidina diminuem de modo significante a lesão de isquemia-reperfusão renal histomorfologicamente. O uso combinado dos dois métodos previne a apoptose via caspase-3 ativa.


Rim, Lesão de isquemia-reperfusão, Dexmedetomidine, Caspase-3, Pré-condicionamento isquêmico, Apoptose


Ojo AO, Wolfe RA, Held PJ. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation. ;63:974-968.

Perico N, Cattaneo D, Sayegh MH. Delayed graft function in kidney transplantation. Lancet. ;364:1814-1827.

Ojo AO, Held PJ, Port FK. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med. ;349:931-940.

Nigwekar SU, Kandula P, Hix JK. Off-pump coronary artery bypass surgery and acute kidney injury: a meta-analysis of randomized and observational studies. Am J Kidney Dis. ;54:423-413.

Collard CD, Gelman S. Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury. Anesthesiology. ;94:1133-1138.

Tsutsui H, Sugiura T, Hayashi K. Moxonidine prevents ischemia/reperfusion-induced renal injury in rats. Eur J Pharmacol. ;603:73-78.

Yazici P, Alizadehshargh S, Akdogan G. Apoptosis: regulatory molecules, relationships with diseases and apoptosis detection methods. Turkiye Klinikleri J Med Sci. ;29:1677-1686.

Faubel S, Edelstein CL. Caspases as drug targets in ischemic organ injury. Immune Endocr Metabol Disord. ;5:269-287.

Noiri E, Gailit J, Sheth D. Cyclic RGD peptides ameliorate ischemic acute renal failure in rats. Kidney Int. ;46:1050-1058.

Friedewald JJ, Rabb H. Inflammatory cells in ischemic acute renal failure. Kidney Int. ;66:486-491.

Tapuria N, Kumar Y, Habib MM. Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury - a review. J Surg Res. ;150:304-330.

Kanoria S, Jalan R, Davies NA. Remote ischaemic preconditioning of the hind limb reduces experimental liver warm ischaemia-reperfusion injury. Br J Surg. ;93:762-768.

Duru S, Koca U, Oztekin S. Antithrombin III pretreatment reduces neutrophil recruitment into lung and skeletal muscle tissues in the rat model of bilateral lower limb ischaemia and reperfusion: a pilot study. Acta Anaesthesiol Scand. ;49:1142-1148.

Feng L, Xiong Y, Cheng F. Effect of ligustrazine on ischemia-reperfusion injury in murine kidney. Transplant Proc. ;36:1949-1951.

Thadhani R, Pascual M, Bonventre JV. Acute renal failure. N Engl J Med. ;334:1460-1448.

Brezis M, Rosen S, Silva P. Renal ischemia: a new perspective. Kidney Int. ;26:383-375.

Caron A, Desrosiers RR, Beliveau R. Kidney ischemia reperfusion regulates expression and distribution of tubulin subunits, beta-actin and rho GTPases in proximal tubules. Arch Biochem Biophys. ;431:46-31.

Gu J, Pamela S, Hailin Z. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care. ;15:R153.

Kocoğlu H, Ozturk H, Ozturk H. Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study. Ren Fail. ;31:74-70.

Williams P, Lopez H, Britt D. Characterization of renal ischemia-reperfusion injury in rats. J Pharmacol Toxicol Methods. ;37:1-7.

Fujii T, Takaoka M, Muraoka T. Preventive effect of lcarnosine on ischemia/reperfusion-induced acute renal failure in rats. Eur J Pharmacol. ;474:261-267.

Hussein Ael-A, Shkeir AA, Sarhan ME. Effects of combined erythropoietin and epidermal growth factor on renal ischaemia/reperfusion injury: a randomized experimental controlled study. BJU Int. ;107:323-328.

Jaeschke H, Farhood A. Kupffer cell activation after no-flow ischemia versus hemorrhagic shock. Free Radic Biol Med. ;33:210-219.

Sanders RD, Maze M. Alpha 2-adrenoceptor agonists. Curr Opin Investig Drugs. ;8:33-25.

Billings FT, Chen SW, Kim M. Alpha 2-adrenergic agonists protect against radiocantrast-induced nephropathy in mice. Am J Physiol Renal Physiol. ;295:748-741.

Ma D, Hossain M, Rajakumaraswamy N. Dexmedetomidine produces its neuroprotective effect via the alpha 2A-adrenoceptor subtype. Eur J Pharmacol. ;502:87-97.

Kuhmonen J, Pokorny J, Miettinen R. Neuroprotective effects of dexmedetomidine in the gerbil hippocampus after transient global ischemia. Anesthesiology. ;87:371-377.

Taoda M, Adachi YU, Uchihashi Y. Effect of dexmedetomidine on the release of 3H]-noradrenaline from rat kidney cortex slices: characterization of alpha2-adrenoceptor. Neurochem Int. ;38:322-317.

Villela NR, Nascimento PVN, Carvalho LR. Effects of dexmedetomidine on renal system and on vasopressin plasma levels. Experimental study in dogs. Rev Bras Anestesiol. ;55:429-440.

Frumento RJ, Logginidou HG, Wahlander S. Dexmedetomidine infusion is associated with enhanced renal function after thoracic surgery. J Clin Anesth. ;18:422-426.

Kulka PJ, Tryba M, Zenz M. Preoperative alpha 2-adrenergic receptor agonists prevent the deterioration of renal function after cardiac surgery: results of a randomized, controlled trial. Crit Care Med. ;24:947-952.

Helbo-Hansen S, Fletcher R, Lundberg D. Clonidine and the sympatico-adrenal response to coronary artery by-pass surgery. Acta Anaesthesiol Scand. ;30:235-242.

Kulka PJ, Tryba M, Zenz M. Dose-response effects of intravenous clonidine on stress response during induction of anesthesia in coronary artery bypass graft patients. Anesth Analg. ;80:263-268.

Flacke JW, Bloor BC, Flacke WE. Reduced narcotic requirement by clonidine with improved hemodynamic and adrenergic stability in patients undergoing coronary bypass surgery. Anesthesiology. ;67:11-19.

Gesek FA. Alpha2-adrenergic receptors activate phospholipase C in renal epithelial cells. Mol Pharmacol. ;50:407-414.

O'Rourke B. Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ Res. ;94:420-432.

Engelhard K, Werner C, Eberspacher E. The effect of the alpha 2-agonist dexmedetomidine and the N-methyldaspartate antagonist S(+)-ketamine on the expression of apoptosis-regulating proteins after incomplete cerebral ischemia and reperfusion in rats. Anesth Analg. ;96:524-531.

Safian RD, Textor SC. Renal-artery stenosis. N Engl J Med. ;344:442-431.

Schrier RW, Wang W. Acute renal failure and sepsis. N Engl J Med. ;351:159-169.

Wever KE, Menting TP, Rovers M. Ischemic preconditioning in the animal kidney, a systematic review and meta-analysis. PLoS ONE. ;7:e32296.

Venugopal V, Laing CM, Ludman A. Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials. Am J Kidney Dis. ;56:1043-1049.

Curtis FG, Vianna PT, Viero RM. Dexmedetomidine and S(+)-ketamine in ischemia and reperfusion injury in the rat kidney. Acta Cir Bras. ;26:202-206.

Diwan V, Kant R, Jaggi AS. Signal mechanism activated by erythropoietin preconditioning and remote renal preconditioning-induced cardioprotection. Mol Cell Biochem. ;315:195-201.

5dcd85260e88259666bf58f3 rba Articles
Links & Downloads

Braz J Anesthesiol

Share this page
Page Sections